Defunct Company
Total Trials
13
As Lead Sponsor
6
As Collaborator
7
Total Enrollment
970
NCT00750191
Placebo-controlled Trial of Transdiscal Radiofrequency Annuloplasty
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2007
Completion: Sep 30, 2012
NCT00749554
Trial of Disc Biacuplasty to Treat Chronic Discogenic Low Back Pain
Phase: Phase 4
Start: Apr 30, 2008
Completion: Not specified
NCT00802997
Trial Assessing Cooled Radiofrequency Denervation as a Treatment for Sacroiliac Joint Pain Using the Sinergy System
Phase: N/A
Start: Jun 30, 2008
Completion: Aug 31, 2011
NCT01158092
Trial Comparing Treatment With SInergy™ System to Conservative Treatment for Chronic Sacroiliac Joint Pain
Start: Jul 31, 2010
NCT01209260
Transseptal Needle Versus Radiofrequency Energy for Left Atrial Access
Role: Collaborator
Start: Nov 30, 2010
Completion: Nov 30, 2012
NCT03199703
Conventional Versus RF Needle Transseptal Puncture for Cryoballoon Ablation
Start: Jan 17, 2017
Completion: Aug 1, 2020
NCT02825979
Early Aggressive Invasive Intervention for Atrial Fibrillation
Start: Jan 31, 2017
Completion: Nov 30, 2022
NCT03451149
Feasibility And Safety Of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Using A Radiofrequency Guidewire
Start: Oct 25, 2017
Completion: Jan 29, 2019
NCT03750435
Non-fluoroscopy Ablation of AF/AT
Start: Oct 8, 2018
Completion: Oct 8, 2019
NCT04645342
Wire Instrumentation Using Radiofrequency Energy to Impact Transseptal Efficiency
Start: Nov 30, 2020
Completion: Feb 2, 2022
NCT05120609
Pilot Study to Evaluate the Self-Management of Gait, Speech, and Dexterity Symptoms in Parkinson's Disease Using a Smartphone Application
Start: Dec 31, 2021
Completion: Dec 31, 2022
NCT05972642
Safety & Efficacy of Non-Invasive Procedures Using Ultrasound-Guided HIFU 'Sonotrip V20' in Symptomatic Uterine Fibroids
Phase: Early Phase 1
Start: Aug 1, 2023
Completion: Dec 1, 2025
NCT06560034
VicorderCS NIBP Validation Study to Review The Ability to Capture Blood Pressure Measurements
Start: Aug 15, 2024
Completion: Aug 1, 2025